ALPS Advisors’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-25,338
| Closed | -$244K | – | 991 |
|
|
2023
Q3 | $244K | Buy |
25,338
+222
| +0.9% | +$2.14K | ﹤0.01% | 926 |
|
|
2023
Q2 | $226K | Buy |
+25,116
| New | +$226K | ﹤0.01% | 969 |
|
|
2022
Q4 | – | Sell |
-13,433
| Closed | -$195K | – | 1062 |
|
|
2022
Q3 | $195K | Sell |
13,433
-1,128
| -8% | -$16.4K | ﹤0.01% | 1004 |
|
|
2022
Q2 | $143K | Sell |
14,561
-10,658
| -42% | -$105K | ﹤0.01% | 1013 |
|
|
2022
Q1 | $372K | Sell |
25,219
-3,055
| -11% | -$45.1K | ﹤0.01% | 550 |
|
|
2021
Q4 | $374K | Buy |
+28,274
| New | +$374K | ﹤0.01% | 723 |
|
|
2020
Q4 | – | Sell |
-22,822
| Closed | -$287K | – | 861 |
|
|
2020
Q3 | $287K | Sell |
22,822
-1,528
| -6% | -$19.2K | ﹤0.01% | 532 |
|
|
2020
Q2 | $295K | Sell |
24,350
-8,040
| -25% | -$97.4K | ﹤0.01% | 562 |
|
|
2020
Q1 | $248K | Sell |
32,390
-3,774
| -10% | -$28.9K | ﹤0.01% | 574 |
|
|
2019
Q4 | $644K | Buy |
+36,164
| New | +$644K | 0.01% | 476 |
|